HCG’s Q1FY24 revenue growth of 4.3% QoQ was mainly driven by day care services. Installation of 5 LINACs (under pay for use model) led to a dip in radiation oncology services impacting revenue and gross margins. Four of the five new LINACs are operational and the management expects to restore its EBITDA margin by the end of Q4FY24, while it may add a few more LINACs in FY25.